Live tape
Top 8, mentions 7d14,299GOOGL2,859 mentions▲ +0.04NVDA2,210 mentions▲ +0.05AMD1,939 mentions▲ +0.08QQQ1,745 mentions▲ +0.05AAPL1,729 mentions▲ +0.05SPY1,558 mentions▲ +0.06TSLA1,164 mentions▲ +0.06SPCX1,095 mentions▲ +0.05

Equity

DAWN

Day One Biopharmaceuticals (DAWN)

DAWN price graph

This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers. We hold too few licensed daily closes of our own for DAWN to draw a line in its place.

Track this symbol on TradingView

Have Day One Biopharmaceuticals (DAWN) insiders bought or sold shares recently?

DAWN has no Form 4 filing in the last 90 days, so there is no summary for that window. The most recent filings we hold are below, the newest dated 23 April 2026.

Form 4

Have Day One Biopharmaceuticals (DAWN) insiders bought or sold shares recently?
ReportedInsiderTypeSharesValue
17 Feb 2026Bender JeremyCHIEF EXECUTIVE OFFICERSell15,459179K USD
17 Feb 2026York Charles N IICOO and CFOSell6,06570K USD
17 Feb 2026VASCONCELLES MICHAELHead of Research and Dev.Sell2,72832K USD
17 Feb 2026Dubow AdamGen Counsel & SecretarySell6,39574K USD
17 Feb 2026Merendino LaurenChief Commercial OfficerSell5,81467K USD
17 Nov 2025York Charles N IICOO and CFOSell4,06236K USD
17 Nov 2025Dubow AdamGen Counsel & SecretarySell4,31939K USD
17 Nov 2025Merendino LaurenChief Commercial OfficerSell3,72633K USD
17 Nov 2025Bender JeremyCHIEF EXECUTIVE OFFICERSell15,894142K USD
Sold9 open-market sales64,462$673K
39 other filings: grants, exercises, tax withholding and transfers, not trades
Have Day One Biopharmaceuticals (DAWN) insiders bought or sold shares recently?
ReportedInsiderTypeSharesValue
23 Apr 2026Bender JeremyCHIEF EXECUTIVE OFFICEROther1,799,031
23 Apr 2026Ramasastry SairaDirectorOther40,485
23 Apr 2026Holles Natalie C.DirectorOther57,310
23 Apr 2026York Charles N IICOO and CFOOther312,025
23 Apr 2026VASCONCELLES MICHAELHead of Research and Dev.Other4,397
23 Apr 2026Dubow AdamGen Counsel & SecretaryOther72,694
23 Apr 2026Josey John A.DirectorOther72,292
23 Apr 2026Merendino LaurenChief Commercial OfficerOther60,157
23 Apr 2026AI Day1 LLC10% OwnerOther12,929,322278.0M USD
15 Feb 2026Bender JeremyCHIEF EXECUTIVE OFFICEROption exercise42,937
15 Feb 2026York Charles N IICOO and CFOOption exercise23,375
15 Feb 2026VASCONCELLES MICHAELHead of Research and Dev.Option exercise7,125

Showing the 12 most recent of 39 compensation filings in this window. The figures above count all of them.

Which funds hold Day One Biopharmaceuticals (DAWN)?

0 of the 45 institutional funds we track reported a Day One Biopharmaceuticals position for the quarter ended 30 Jun 2026; the latest of those filings landed 14 Aug 2026.

Form 13F

Which funds hold Day One Biopharmaceuticals (DAWN)?
FundPositionSharesValueShares q/q
AQR Capital ManagementExited
Balyasny Asset ManagementExited
D. E. Shaw & Co.Exited
Fisher Asset ManagementExited
Man GroupExited
Marshall WaceExited
Millennium ManagementExited
Point72 Asset ManagementExited
Renaissance TechnologiesExited
Soros Fund ManagementExited

Day One Biopharmaceuticals (DAWN): frequently asked questions

From live data

Have Day One Biopharmaceuticals insiders bought or sold shares recently?

No Day One Biopharmaceuticals insider has filed a Form 4 in the last 90 days; the most recent filing we hold is dated 23 Apr 2026 (SEC Form 4). See Insiders

0 of 45

Which funds own Day One Biopharmaceuticals?

0 of the 45 funds we track reported a Day One Biopharmaceuticals position for the quarter ended 30 Jun 2026, per their SEC Form 13F filings. The largest reported positions were AQR Capital Management, Balyasny Asset Management and D. E. Shaw & Co. See Funds

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.

References
  1. TradingViewthe price chart widget, drawn by TradingView from their own data
  2. SEC EDGARForm 4 filings (insider transactions)
  3. SEC EDGAR13F filings